Rbf Capital, LLC Harvard Bioscience Inc Transaction History
Rbf Capital, LLC
- $1.61 Billion
- Q1 2025
A detailed history of Rbf Capital, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Rbf Capital, LLC holds 180,912 shares of HBIO stock, worth $59,700. This represents 0.01% of its overall portfolio holdings.
Number of Shares
180,912Holding current value
$59,700% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
26.2MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.39MShares$1.12 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$938,4040.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$721,8750.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$705,7870.0% of portfolio
-
Royce & Associates LP1.78MShares$586,7050.01% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $13.7M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...